Published in J Biol Chem on March 17, 2010
Exposure of R169 controls protein C activation and autoactivation. Blood (2012) 1.52
Ligand binding to anion-binding exosites regulates conformational properties of thrombin. J Biol Chem (2013) 0.93
The transition of prothrombin to thrombin. J Thromb Haemost (2013) 0.93
Autoactivation of thrombin precursors. J Biol Chem (2013) 0.92
Crystal structure of thrombin in complex with S-variegin: insights of a novel mechanism of inhibition and design of tunable thrombin inhibitors. PLoS One (2011) 0.89
Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector. Proc Natl Acad Sci U S A (2012) 0.88
GpIbα interacts exclusively with exosite II of thrombin. J Mol Biol (2013) 0.84
The tick-derived anticoagulant madanin is processed by thrombin and factor Xa. PLoS One (2013) 0.82
Dynamics Govern Specificity of a Protein-Protein Interface: Substrate Recognition by Thrombin. PLoS One (2015) 0.82
Identification of protease exosite-interacting peptides that enhance substrate cleavage kinetics. Biol Chem (2012) 0.80
Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction. Blood (2011) 0.78
Evolution of thrombin and other hemostatic proteases by survey of protochordate, hemichordate, and echinoderm genomes. J Mol Evol (2012) 0.77
Non-invasive imaging and cellular tracking of pulmonary emboli by near-infrared fluorescence and positron-emission tomography. Nat Commun (2015) 0.77
Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants. Biochim Biophys Acta (2011) 0.77
Thrombin Cleavage of Plasmodium falciparum Erythrocyte Membrane Protein 1 Inhibits Cytoadherence. MBio (2016) 0.76
Rational Design of Protein C Activators. Sci Rep (2017) 0.75
Functional analyses yield detailed insight into the mechanism of thrombin inhibition by the antihemostatic salivary protein cE5 from Anopheles gambiae. J Biol Chem (2017) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun (1967) 18.32
Thrombin signalling and protease-activated receptors. Nature (2000) 9.27
Serine protease mechanism and specificity. Chem Rev (2002) 5.46
Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost (2005) 4.64
A dual thrombin receptor system for platelet activation. Nature (1998) 3.96
Protease-activated receptor 3 is a second thrombin receptor in humans. Nature (1997) 3.70
Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A (1998) 3.50
Domains specifying thrombin-receptor interaction. Nature (1991) 3.32
Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature (2001) 3.15
A role for thrombin receptor signaling in endothelial cells during embryonic development. Science (2001) 2.55
PAR3 is a cofactor for PAR4 activation by thrombin. Nature (2000) 2.55
Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med (1998) 2.42
Serine peptidases: classification, structure and function. Cell Mol Life Sci (2008) 2.17
Protease-activated receptors in cardiovascular diseases. Circulation (2006) 2.10
Refined structure of the hirudin-thrombin complex. J Mol Biol (1991) 2.06
Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature (2000) 2.04
Thrombin and platelet activation. Chest (2003) 1.89
Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci U S A (2001) 1.84
Thrombin. Mol Aspects Med (2008) 1.80
Molecular dissection of Na+ binding to thrombin. J Biol Chem (2004) 1.72
Exosites in the substrate specificity of blood coagulation reactions. J Thromb Haemost (2007) 1.61
Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis. Circulation (2006) 1.60
The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem (1992) 1.53
Glu-192----Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. Proc Natl Acad Sci U S A (1991) 1.46
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Biochemistry (1994) 1.46
Thrombin. Ann N Y Acad Sci (1986) 1.44
Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med (2000) 1.44
The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. Protein Sci (1994) 1.44
Functional mapping of the surface residues of human thrombin. J Biol Chem (1995) 1.38
Molecular mapping of thrombin-receptor interactions. Proteins (2001) 1.32
Structural identification of the pathway of long-range communication in an allosteric enzyme. Proc Natl Acad Sci U S A (2008) 1.31
Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4. Proc Natl Acad Sci U S A (2007) 1.23
Structural basis for thrombin activation of a protease-activated receptor: inhibition of intramolecular liganding. Chem Biol (2003) 1.15
Crystal structure of the complex between thrombin and the central "E" region of fibrin. Proc Natl Acad Sci U S A (2004) 1.13
Further localization of binding sites for thrombin and protein C in human thrombomodulin. J Biol Chem (1990) 1.09
The action of thrombin on peptide p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions. Biochim Biophys Acta (1983) 1.08
Crystal structure of bovine beta-trypsin at 1.5 A resolution in a crystal form with low molecular packing density. Active site geometry, ion pairs and solvent structure. J Mol Biol (1989) 1.08
Thrombomodulin changes the molecular surface of interaction and the rate of complex formation between thrombin and protein C. J Biol Chem (2004) 1.08
Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1. J Biol Chem (2007) 1.04
Structure and interaction modes of thrombin. Blood Cells Mol Dis (2006) 1.04
Structural origins of substrate discrimination in trypsin and chymotrypsin. Biochemistry (1995) 1.03
Energetics of thrombin-thrombomodulin interaction. Biochemistry (1997) 1.00
Mutation of W215 compromises thrombin cleavage of fibrinogen, but not of PAR-1 or protein C. Biochemistry (2000) 0.99
Mutant N143P reveals how Na+ activates thrombin. J Biol Chem (2009) 0.97
Interaction of thrombin with PAR1 and PAR4 at the thrombin cleavage site. Biochemistry (2007) 0.97
Site-specific dissection of substrate recognition by thrombin. Nat Biotechnol (1997) 0.97
Dissecting substrate recognition by thrombin using the inactive mutant S195A. Biophys Chem (2003) 0.96
Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates and inhibitors. Biochemistry (1992) 0.95
Enhancing protein C interaction with thrombin results in a clot-activated anticoagulant. Nature (1992) 0.95
Activation of protein C by the thrombin-thrombomodulin complex: cooperative roles of Arg-35 of thrombin and Arg-67 of protein C. Proc Natl Acad Sci U S A (2006) 0.94
The conformation of the activation peptide of protein C is influenced by Ca2+ and Na+ binding. J Biol Chem (2004) 0.93
Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly. Biochemistry (2006) 0.93
Interaction of the factor XIII activation peptide with alpha -thrombin. Crystal structure of its enzyme-substrate analog complex. J Biol Chem (2000) 0.91
Protease-activated receptor 4-like peptides bind to thrombin through an optimized interaction with the enzyme active site surface. Arch Biochem Biophys (2002) 0.91
The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1. Eur J Biochem (2001) 0.89
Three-dimensional modeling of thrombin-fibrinogen interaction. J Biol Chem (2002) 0.83
Mutation of protease domain residues Lys37-39 in human protein C inhibits activation by the thrombomodulin-thrombin complex without affecting activation by free thrombin. J Biol Chem (1996) 0.83
Employing mutants to study thrombin residues responsible for factor XIII activation peptide recognition: a kinetic study. Biochemistry (2007) 0.81
The changing face of HIV in China. Nature (2008) 3.39
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol (2003) 3.10
Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China. PLoS Med (2006) 2.37
Evolution of enzyme cascades from embryonic development to blood coagulation. Trends Biochem Sci (2002) 1.96
Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist. Arterioscler Thromb Vasc Biol (2007) 1.80
Role of Na+ and K+ in enzyme function. Physiol Rev (2006) 1.80
Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china. J Virol (2004) 1.76
Molecular dissection of Na+ binding to thrombin. J Biol Chem (2004) 1.72
The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A. Blood (2011) 1.71
Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains. Blood (2005) 1.64
Protective signaling by activated protein C is mechanistically linked to protein C activation on endothelial cells. J Biol Chem (2006) 1.58
Exposure of R169 controls protein C activation and autoactivation. Blood (2012) 1.52
High prevalence of HIV infection among women and their children in Henan Province, China. J Acquir Immune Defic Syndr (2003) 1.47
Conformational selection or induced fit? A critical appraisal of the kinetic mechanism. Biochemistry (2012) 1.39
Structural identification of the pathway of long-range communication in an allosteric enzyme. Proc Natl Acad Sci U S A (2008) 1.31
Rapid kinetics of Na+ binding to thrombin. J Biol Chem (2006) 1.29
Human genital epithelial cells capture cell-free human immunodeficiency virus type 1 and transmit the virus to CD4+ Cells: implications for mechanisms of sexual transmission. J Infect Dis (2003) 1.29
Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1. J Virol (2002) 1.25
Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4. Proc Natl Acad Sci U S A (2007) 1.23
Conformational selection in trypsin-like proteases. Curr Opin Struct Biol (2012) 1.20
Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide. Vaccine (2008) 1.19
The thrombin mutant W215A/E217A shows safe and potent anticoagulant and antithrombotic effects in vivo. J Biol Chem (2002) 1.19
HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. AIDS (2003) 1.16
Evolution of peptidase diversity. J Biol Chem (2008) 1.16
Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates. Blood (2007) 1.12
Crystal structure of thrombin in a self-inhibited conformation. J Biol Chem (2006) 1.11
Iron deficiency anaemia can be improved after eradication of Helicobacter pylori. Postgrad Med J (2010) 1.11
The anticoagulant thrombin mutant W215A/E217A has a collapsed primary specificity pocket. J Biol Chem (2004) 1.10
Biochemical characterization and crystal structure of endoglucanase Cel5A from the hyperthermophilic Thermotoga maritima. J Struct Biol (2010) 1.10
Engineering thrombin for selective specificity toward protein C and PAR1. J Biol Chem (2010) 1.09
Genetic characterization of diverse HIV-1 strains in an immigrant population living in New York City. J Acquir Immune Defic Syndr (2006) 1.08
Thrombomodulin changes the molecular surface of interaction and the rate of complex formation between thrombin and protein C. J Biol Chem (2004) 1.08
Identification of QTLs with main, epistatic and QTL × environment interaction effects for salt tolerance in rice seedlings under different salinity conditions. Theor Appl Genet (2012) 1.07
High-resolution NMR spectra in inhomogeneous fields via IDEAL (intermolecular dipolar-interaction enhanced all lines) method. J Am Chem Soc (2004) 1.07
Allostery in trypsin-like proteases suggests new therapeutic strategies. Trends Biotechnol (2011) 1.07
Redesigning the monovalent cation specificity of an enzyme. Proc Natl Acad Sci U S A (2003) 1.05
Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. Chem Biol (2004) 1.05
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine. PLoS One (2010) 1.05
Conformational selection is a dominant mechanism of ligand binding. Biochemistry (2013) 1.05
Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain. J Virol (2005) 1.03
Mechanism of Na(+) binding to thrombin resolved by ultra-rapid kinetics. Biophys Chem (2007) 1.01
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine. PLoS One (2010) 1.01
The effects of cantharidin and cantharidin derivates on tumour cells. Anticancer Agents Med Chem (2009) 1.00
Phylodynamics of HIV-1 subtype B among the men-having-sex-with-men (MSM) population in Hong Kong. PLoS One (2011) 1.00
A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer. J Thorac Oncol (2012) 1.00
Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain. Virology (2005) 1.00
QTL analysis of Na+ and K+ concentrations in roots and shoots under different levels of NaCl stress in rice (Oryza sativa L.). PLoS One (2012) 0.99
Crystal structure of thrombin in complex with fibrinogen gamma' peptide. Biophys Chem (2006) 0.99
Design, construction, and characterization of a dual-promoter multigenic DNA vaccine directed against an HIV-1 subtype C/B' recombinant. J Acquir Immune Defic Syndr (2008) 0.99
Increased genetic diversity of HIV-1 circulating in Hong Kong. PLoS One (2010) 0.99
Crystallographic and kinetic evidence of allostery in a trypsin-like protease. Biochemistry (2011) 0.98
Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J Med Virol (2006) 0.97
Mutant N143P reveals how Na+ activates thrombin. J Biol Chem (2009) 0.97
Crystal structures of prethrombin-2 reveal alternative conformations under identical solution conditions and the mechanism of zymogen activation. Biochemistry (2011) 0.97
Important role of the cys-191 cys-220 disulfide bond in thrombin function and allostery. J Biol Chem (2007) 0.96
Dissecting substrate recognition by thrombin using the inactive mutant S195A. Biophys Chem (2003) 0.96
Crystal structure of prethrombin-1. Proc Natl Acad Sci U S A (2010) 0.96
A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivo. J Biol Chem (2005) 0.96
Crystal structure of the anticoagulant slow form of thrombin. J Biol Chem (2002) 0.96
A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination. PLoS One (2009) 0.95
Energetic and structural consequences of perturbing Gly-193 in the oxyanion hole of serine proteases. J Biol Chem (2005) 0.95
Mechanism of the anticoagulant activity of thrombin mutant W215A/E217A. J Biol Chem (2009) 0.95
Chemical library and structure-activity relationships of 11-demethyl-12-oxo calanolide A analogues as anti-HIV-1 agents. J Med Chem (2008) 0.94
Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke. Stroke (2011) 0.94
Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancer. Biomarkers (2010) 0.93
The conformation of the activation peptide of protein C is influenced by Ca2+ and Na+ binding. J Biol Chem (2004) 0.93
Murine thrombin lacks Na+ activation but retains high catalytic activity. J Biol Chem (2006) 0.93
Rising epidemic of HIV-1 infections among general populations in Fujian, China. J Acquir Immune Defic Syndr (2012) 0.93
Association of the CHRNA3 locus with lung cancer risk and prognosis in Chinese Han population. J Thorac Oncol (2010) 0.92
Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase. J Med Chem (2007) 0.92
Autoactivation of thrombin precursors. J Biol Chem (2013) 0.92
Three-dimensional models of proteases involved in patterning of the Drosophila Embryo. Crucial role of predicted cation binding sites. J Biol Chem (2002) 0.92
Crystal structure of prothrombin reveals conformational flexibility and mechanism of activation. J Biol Chem (2013) 0.92
Ser(214) is crucial for substrate binding to serine proteases. J Biol Chem (2002) 0.92
Stabilization of the E* form turns thrombin into an anticoagulant. J Biol Chem (2009) 0.91
The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes. J Virol Methods (2007) 0.90
The thrombin epitope recognizing thrombomodulin is a highly cooperative hot spot in exosite I. J Biol Chem (2002) 0.90
PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice. J Clin Invest (2013) 0.90
Residue Asp-189 controls both substrate binding and the monovalent cation specificity of thrombin. J Biol Chem (2003) 0.89
Evidence of the E*-E equilibrium from rapid kinetics of Na+ binding to activated protein C and factor Xa. J Phys Chem B (2010) 0.89
Crystal structure studies on sulfur oxygenase reductase from Acidianus tengchongensis. Biochem Biophys Res Commun (2008) 0.89
HIV-1 transactivator protein induction of suppressor of cytokine signaling-2 contributes to dysregulation of IFN{gamma} signaling. Blood (2009) 0.89
Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus. PLoS One (2006) 0.89
Hirudin binding reveals key determinants of thrombin allostery. J Biol Chem (2005) 0.88
Chinese pediatric and adolescent primary tracheobronchial tumors: a hospital-based study. Pediatr Surg Int (2011) 0.88
Stratified active archaeal communities in the sediments of Jiulong River estuary, China. Front Microbiol (2012) 0.88
High resolution crystal structures of free thrombin in the presence of K(+) reveal the molecular basis of monovalent cation selectivity and an inactive slow form. Biophys Chem (2006) 0.88